Photobiomodulation targets mitochondrial signaling systems to improve cellular bioenergetic processes. Age-related macular degeneration shows mitochondrial dysfunction contributing to disease development and progression. Multiwavelength PBM improved clinical and anatomical outcomes in early-intermediate nonexudative (dry) age-related macular degeneration. Photobiomodulation offers a novel treatment with a unique mechanism and mode of delivery for dry AMD.
